<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30447054</article-id>
<article-id pub-id-type="pmc">6393687</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.501</article-id>
<article-id pub-id-type="publisher-id">MGG3501</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Clinical Report</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Clinical Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mutations in <italic>STAG2</italic> cause an X‐linked cohesinopathy associated with undergrowth, developmental delay, and dysmorphia: Expanding the phenotype in males</article-title>
<alt-title alt-title-type="left-running-head">MULLEGAMA et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mgg3501-cr-0001">
<name>
<surname>Mullegama</surname>
<given-names>Sureni V.</given-names>
</name>
<xref ref-type="aff" rid="mgg3501-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="mgg3501-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3501-cr-0002">
<name>
<surname>Klein</surname>
<given-names>Steven D.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8634-0388</contrib-id>
<xref ref-type="aff" rid="mgg3501-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="mgg3501-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3501-cr-0003">
<name>
<surname>Signer</surname>
<given-names>Rebecca H.</given-names>
</name>
<xref ref-type="aff" rid="mgg3501-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3501-cr-0004">
<collab collab-type="authors">UCLA Clinical Genomics Center</collab>
<xref ref-type="aff" rid="mgg3501-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3501-cr-0005">
<name>
<surname>Vilain</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="mgg3501-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg3501-cr-0006">
<name>
<surname>Martinez‐Agosto</surname>
<given-names>Julian A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6776-6949</contrib-id>
<address>
<email>julianmartinez@mednet.ucla.edu</email>
</address>
<xref ref-type="aff" rid="mgg3501-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="mgg3501-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="mgg3501-aff-0006">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="mgg3501-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Molecular and Human Genetics</named-content>
<institution>Baylor College of Medicine</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="mgg3501-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Human Genetics</named-content>
<named-content content-type="organisation-division">David Geffen School of Medicine</named-content>
<institution>University of California, Los Angeles</institution>
<named-content content-type="city">Los Angeles</named-content>
<country>California</country>
</aff>
<aff id="mgg3501-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Division of Medical Genetics, Department of Pediatrics</named-content>
<named-content content-type="organisation-division">David Geffen School of Medicine</named-content>
<institution>University of California, Los Angeles</institution>
<named-content content-type="city">Los Angeles</named-content>
<country>California</country>
</aff>
<aff id="mgg3501-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Pathology and Laboratory Medicine, David Geffen School of Medicine</named-content>
<institution>University of California, Los Angeles</institution>
<named-content content-type="city">Los Angeles</named-content>
<country>California</country>
</aff>
<aff id="mgg3501-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Genomic and Precision Medicine</named-content>
<institution>Children’s National Hospital</institution>
<named-content content-type="city">Washington</named-content>
<named-content content-type="country-part">District of Columbia</named-content>
</aff>
<aff id="mgg3501-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">UCLA Clinical Genomics Center, David Geffen School of Medicine</named-content>
<institution>University of California</institution>
<named-content content-type="city">Los Angeles, Los Angeles</named-content>
<country>California</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Julian A. Martinez‐Agosto, Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.<break></break>
Email: <email>julianmartinez@mednet.ucla.edu</email><break></break></corresp>
<fn id="mgg3501-note-1001">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>2</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.2019.7.issue-2</issue-id>
<elocation-id>e00501</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>27</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-7-na.pdf" xlink:type="simple"></self-uri>
<abstract id="mgg3501-abs-0001">
<title>Abstract</title>
<sec id="mgg3501-sec-0001">
<title>Background</title>
<p>The cohesin complex is a multi‐subunit protein complex which regulates sister chromatid cohesion and separation during cellular division. In addition, this evolutionarily conserved protein complex plays an integral role in DNA replication, DNA repair, and the regulation of transcription. The core complex is composed of four subunits: RAD21, SMC1A, SMC3, and STAG1/2. Mutations in these proteins have been implicated in human developmental disorders collectively termed “cohesinopathies.”</p>
</sec>
<sec id="mgg3501-sec-0002">
<title>Methods</title>
<p>Using clinical exome sequencing, we have previously identified three female cases with heterozygous <italic>STAG2</italic> mutations and overlapping syndromic phenotypes. Subsequently, a familial missense variant was identified in five male family members.</p>
</sec>
<sec id="mgg3501-sec-0003">
<title>Results</title>
<p>We now present the case of a 4‐year‐old male with developmental delay, failure to thrive, short stature, and polydactyly with a likely pathogenic <italic>STAG2</italic> de novo missense hemizygous variant, c.3027A&gt;T, p.Lys1009Asn. Furthermore, we compare the phenotypes of the four previously reported <italic>STAG2</italic> variants with our case.</p>
</sec>
<sec id="mgg3501-sec-0004">
<title>Conclusion</title>
<p>We conclude that mutations in <italic>STAG2</italic> cause a novel constellation of sex‐specific cohesinopathy‐related phenotypes and are furthermore, essential for neurodevelopment, human growth, and behavioral development.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg3501-kwd-0001">clinical exome sequencing</kwd>
<kwd id="mgg3501-kwd-0002">cohesin complex</kwd>
<kwd id="mgg3501-kwd-0003">cohesin‐associated genes</kwd>
<kwd id="mgg3501-kwd-0004">cohesinopathies</kwd>
<kwd id="mgg3501-kwd-0005">human growth</kwd>
<kwd id="mgg3501-kwd-0006">neurodevelopment</kwd>
<kwd id="mgg3501-kwd-0007">reanalysis</kwd>
<kwd id="mgg3501-kwd-0008">
<italic>STAG2</italic>
</kwd>
<kwd id="mgg3501-kwd-0009">X‐linked gene</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Center for Advancing Translational Sciences</funding-source>
<award-id>UL1TR000124</award-id>
</award-group>
<award-group>
<funding-source>Autism Speaks</funding-source>
<award-id>9172</award-id>
</award-group>
<award-group>
<funding-source>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding-source>
<award-id>P50‐HD‐055784</award-id>
</award-group>
<award-group>
<funding-source>NIH Clinical Center</funding-source>
<award-id>T32GM008042</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<page-count count="6"></page-count>
<word-count count="7835"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>mgg3501</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.0 mode:remove_FC converted:27.02.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg3501-cit-1001" publication-type="journal">
<string-name>
<surname>Mullegama</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Signer</surname>
<given-names>RH</given-names>
</string-name>, <collab collab-type="authors">UCLA Clinical Genomics Center</collab>
, <string-name>
<surname>Vilain</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Martinez‐Agosto</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Mutations in <italic>STAG2</italic> cause an X‐linked cohesinopathy associated with undergrowth, developmental delay, and dysmorphia: Expanding the phenotype in males</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2019</year>;<volume>7</volume>:<elocation-id>e501</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.501</pub-id>
</mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="mgg3501-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Cohesinopathies are rare multisystem developmental disorders associated with defects in the cohesin complex which enables chromosome segregation and modulates gene transcription (Di Benedetto et al., <xref ref-type="ref" rid="mgg3501-bib-0005">2013</xref>). The cohesin complex is composed of four cores proteins, SMC1A, SMC2, RAD21, and STAG1/2. The interaction of the cohesin complex with chromosomes is regulated by several proteins (<italic>NIPBL, ESCO2, HDAC8, DDX11, SGOL1</italic>,<italic> WAPL</italic>,<italic> PDS5A, PLK1, AURKB,</italic> and <italic>ATRX</italic>) (Gard et al., <xref ref-type="ref" rid="mgg3501-bib-0006">2009</xref>). The majority of these genes have been reported in human disease (Ball, Chen, &amp; Yokomori, <xref ref-type="ref" rid="mgg3501-bib-0001">2014</xref>; Barbero, <xref ref-type="ref" rid="mgg3501-bib-0002">2013</xref>; Gerkes, Kevie‐Kersemaekers, Yakin, Smeets, &amp; Ravenswaaij‐Arts, <xref ref-type="ref" rid="mgg3501-bib-0007">2010</xref>; McNairn &amp; Gerton, <xref ref-type="ref" rid="mgg3501-bib-0011">2008</xref>; Musio &amp; Krantz, <xref ref-type="ref" rid="mgg3501-bib-0013">2010</xref>; Skibbens et al., <xref ref-type="ref" rid="mgg3501-bib-0020">2013</xref>). Recently, we described the first reported de novo heterozygous loss‐of‐function variants in the X‐linked Stromal Antigen 2 (<italic>STAG2,</italic> OMIM: 300826) gene, in three females with common phenotypes including microcephaly, microtia, hearing loss, developmental delay, dysmorphic features, language delay, congenital heart defect, and clinodactyly of the 5th finger (Mullegama et al., <xref ref-type="ref" rid="mgg3501-bib-0012">2017</xref>). Subsequently, a familial <italic>STAG2</italic> germline hemizygous missense mutation in five males was recently identified that exhibited an overlapping yet milder phenotype than our published female <italic>STAG2</italic> cases. This included moderate intellectual deficiency, short stature, peculiar facies, cleft palate, and unilateral deafness (Soardi et al., <xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>). Here, we describe the first de novo hemizygous missense <italic>STAG2</italic> variant in a 4‐year‐old male and further define the phenotype of <italic>STAG2</italic> mutations.</p>
</sec>
<sec id="mgg3501-sec-0006">
<label>2</label>
<title>CLINICAL REPORT</title>
<p>The proband was born at 39 weeks’ gestation via cesarean section to a 31‐year‐old gravida 3, para 3 mother, and a 37‐year‐old father. Pregnancy was not significant for any major medical problems, teratogenic exposures, or hospitalizations. The parents were of Czech/Slovakia and Scottish/Irish ancestry, and family history was negative for consanguinity. Mother has hypothyroidism, mild hearing loss, attention deficit disorder, and delayed puberty. Depression and anxiety disorder runs on the maternal side of the family. The paternal lineage has a history of schizophrenia. Patient has two other siblings who are healthy, with no reported developmental or physical abnormalities. Birthweight was 1993.71 g (&lt;1st percentile) and length 45.72 cm (&lt;3rd percentile). He presented with early onset failure to thrive. Development was delayed: He crawled at 14 months, independently sat at 13 months, stood up and walked at 16 months, spoke his first words at 13 months, and used small phrases at 17 months. Brain MRI at 1 year of age did not reveal any brain malformations. He had foot surgery when he was 1‐year old to correct polydactyly. He had pes planus requiring orthoses. His audiology testing was normal. At 3 years of age, he started receiving hormone replacement for his growth hormone deficiency. Physical therapy evaluation at this time revealed decreased muscle tone in his lower extremities and abnormalities in gait suggestive of cerebellar dysfunction. At 4‐year‐old weight was 13.9 kg (7th percentile), length was 98 cm (15th percentile), and head circumference was 46 cm (&lt;1st percentile). Dysmorphic features consisted of microcephaly, high anterior hairline, mild frontal bossing, prominent cheeks, triangular face (Figure <xref ref-type="fig" rid="mgg3501-fig-0001">1</xref>a), and 5th digit clinodactyly. He had speech delay with articulation difficulties and received speech, occupational, and physical therapies. The proband was referred to a genetics clinic to obtain comprehensive cytogenetic and molecular testing. The proband underwent a chromosomal SNP array (Affymetrix Genome‐wide 6.0 SNP‐microarray) which revealed no abnormality. Due to his facial gestalt resembling Russell‐Silver Syndrome, methylation and copy number analysis for chromosome 11p15 and UPD for chromosome 7 testing was performed which were within normal limits. Clinical exome sequencing (CES) did not reveal any known disease‐associated gene variants. Two years after initial CES testing, reanalysis was performed.</p>
<fig fig-type="Figure" id="mgg3501-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>(a) Four‐year‐old male with dysmorphic features consisting of microcephaly, high anterior hairline, mild frontal bossing, prominent cheeks, and triangular face. (b) Schematic representation of the STAG2 protein. The p.Arg69* and p.Ala638Valfs*10 are LOF variants in two females. The p.Ser327Asn is a missense variant present in a female. The p.Lys1009Asn is the proband's variant (in red). (c) Three‐dimensional structural modeling of STAG2 demonstrating effects on protein structure</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-7-na-g001"></graphic>
</fig>
</sec>
<sec id="mgg3501-sec-0007">
<label>3</label>
<title>METHODS</title>
<sec id="mgg3501-sec-0008">
<label>3.1</label>
<title>Ethical compliance</title>
<p>All samples and information were collected after informed consent was obtained and in accordance with local Institutional Review Board (IRB) approved protocol from the University of California, Los Angeles (UCLA).</p>
</sec>
<sec id="mgg3501-sec-0009">
<label>3.2</label>
<title>Clinical exome sequencing (CES)</title>
<p>Clinical exome sequencing was performed at the UCLA Clinical Genomics Center, on DNA of the proband and both parents, as previously described (Lee et al., <xref ref-type="ref" rid="mgg3501-bib-0009">2014</xref>).</p>
</sec>
<sec id="mgg3501-sec-0010">
<label>3.3</label>
<title>Pymol modeling of mutation</title>
<p>The STAG two protein file was downloaded from the Protein Data Bank (PBD, File 4PJU), which was then opened in PyMol v1.7.4.5. Protein was visualized in Cartoon Mode, and then, residue 1,009 was selected and cleaned with the “Cartoon Clean Tool.” Residue 1,009 was changed from Lys to Asn using the mutagenesis wizard. The rotomer with the highest likelihood was selected. Associated protein changes were analyzed via selection of all structure within 5 angstroms, and then, the protein was cleaned accordingly (Schrodinger, <xref ref-type="ref" rid="mgg3501-bib-0017">2015a</xref>, <xref ref-type="ref" rid="mgg3501-bib-0018">2015b</xref>, <xref ref-type="ref" rid="mgg3501-bib-0019">2015c</xref>).</p>
</sec>
</sec>
<sec id="mgg3501-sec-0011">
<label>4</label>
<title>RESULTS</title>
<sec id="mgg3501-sec-0012">
<label>4.1</label>
<title>Reanalysis of CES identifies a de novo hemizygous variant in <italic>STAG2</italic>
</title>
<p>Within the primary gene list, no established clinically significant single‐nucleotide variants (SNVs) or small deletions and insertions (&lt;10 bp) were identified. Outside of the primary gene list, reanalysis identified a hemizygous c.3027A&gt;T (p.Lys1009Asn) variant in <italic>STAG2</italic> (Genbank: <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NC_000023.10">NC_000023.10</ext-link> (123094475–123236506), Supporting Information Table <xref ref-type="supplementary-material" rid="mgg3501-sup-0002">S1</xref>). The variant is absent from public databases including Exome Aggregation Consortium (ExAC) and Genome Aggregation Database (gnomAD). The ExAC population database predicts that <italic>STAG2</italic> is depleted of missense variants in healthy populations (90 observed missense variants compared to the 258 expected missense variants), suggesting that this class of variants may be deleterious. Functional prediction algorithms such as Poly‐Phen and Sift predict this variant to be damaging. The evolutionarily conserved amino acid position is located at the end of the evolutionarily conserved GR functional domain (Figure <xref ref-type="fig" rid="mgg3501-fig-0001">1</xref>b,c) (Schrodinger, <xref ref-type="ref" rid="mgg3501-bib-0017">2015a</xref>, <xref ref-type="ref" rid="mgg3501-bib-0018">2015b</xref>, <xref ref-type="ref" rid="mgg3501-bib-0019">2015c</xref> ). The variant was initially classified as a variant of unknown clinical significance based on the American College of Medical Genetics and Genomics variant assessment (Richards et al., <xref ref-type="ref" rid="mgg3501-bib-0016">2015</xref>) (Supporting Information Table <xref ref-type="supplementary-material" rid="mgg3501-sup-0002">S1</xref>). Since then, <italic>STAG2</italic> variants have been recently been associated with a new clinical entity (Mullegama et al., <xref ref-type="ref" rid="mgg3501-bib-0012">2017</xref>; Soardi et al., <xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>). Based on the effects of the missense variant on the protein structure (Figure <xref ref-type="fig" rid="mgg3501-fig-0001">1</xref>c), this variant, p.Lys1009Asn, was reclassified as likely pathogenic. Analysis of the reads covering the same base from CES in the mother and father confirms no evidence of even low abundance mutation, confirming that the mutation is de novo in the proband (Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3501-sup-0001">S1</xref>a–c).</p>
</sec>
</sec>
<sec id="mgg3501-sec-0013">
<label>5</label>
<title>DISCUSSION</title>
<p>This case further confirms that pathogenic variants in <italic>STAG2</italic> result in a novel cohesinopathy. The first reports of <italic>STAG2</italic> copy number variants were identified in 33 males with chromosome Xq25 duplications, involving <italic>STAG2,</italic> with intellectual disability, behavioral problems, seizures, malar flatness, and prognathism (Bonnet et al., <xref ref-type="ref" rid="mgg3501-bib-0003">2009</xref>; Kumar et al., <xref ref-type="ref" rid="mgg3501-bib-0008">2015</xref>; Leroy et al., <xref ref-type="ref" rid="mgg3501-bib-0010">2016</xref>; Philippe et al., <xref ref-type="ref" rid="mgg3501-bib-0014">2013</xref>; Yingjun et al., <xref ref-type="ref" rid="mgg3501-bib-0024">2015</xref>). Shortly after, we described three cases of de novo heterozygous <italic>STAG2</italic> variants in females associated with a distinct phenotype that affects growth, nervous system development, hearing, and limb formation (Table <xref ref-type="table" rid="mgg3501-tbl-0001">1</xref>) (Mullegama et al., <xref ref-type="ref" rid="mgg3501-bib-0012">2017</xref>). Subsequently, a familial <italic>STAG2</italic> missense mutation was identified in one family with five affected males. These five cases presented with moderate cognitive delay, growth retardation, peculiar facies, cleft palate, and unilateral deafness (Soardi et al., <xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>). To further solidify the gender‐specific phenotype associated with <italic>STAG2</italic> hemizygosity, we compared the phenotype of our proband to female <italic>STAG2</italic> LOF pathogenic variants and also to the established cohesinopathies (Table <xref ref-type="table" rid="mgg3501-tbl-0001">1</xref> and Supporting Information Table <xref ref-type="supplementary-material" rid="mgg3501-sup-0002">S2</xref>). We demonstrate that they share the core clinical findings of cognitive delay, growth retardation, neuropsychiatric behaviors, microcephaly, craniofacial dysmorphia, and syndactyly (Supporting Information Table <xref ref-type="supplementary-material" rid="mgg3501-sup-0002">S2</xref>). It appears that decreased dosage of <italic>STAG2</italic> has a more severe phenotype than increased dosage of <italic>STAG2</italic> (Table <xref ref-type="table" rid="mgg3501-tbl-0001">1</xref>)<italic>.</italic> However, the discovery of additional patients with <italic>STAG2</italic> pathogenic variants will help identify whether there is a dosage effect of <italic>STAG2</italic> on phenotype. Further, we theorize that decreased dosage of <italic>STAG2</italic> is associated with a neurodevelopmental phenotype, growth retardation, and craniofacial dysmorphia.</p>
<table-wrap id="mgg3501-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Comparison of <italic>STAG2</italic> variants</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="left" colspan="1" rowspan="1" valign="top">De novo missense</th>
<th align="left" colspan="1" rowspan="1" valign="top">Familial missense<xref ref-type="fn" rid="mgg3501-note-0003">[Link]</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">De novo LOF<xref ref-type="fn" rid="mgg3501-note-0004">[Link]</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">CNVs<xref ref-type="fn" rid="mgg3501-note-0005">[Link]</xref>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Mutation</td>
<td align="left" colspan="1" rowspan="1">p.Lys1009Asn</td>
<td align="left" colspan="1" rowspan="1">p.Ser327Asn</td>
<td align="left" colspan="1" rowspan="1">p.Arg69<xref ref-type="fn" rid="mgg3501-note-0006">[Link]</xref>
</td>
<td align="left" colspan="1" rowspan="1">Duplications</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender</td>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="left" colspan="1" rowspan="1">Female</td>
<td align="left" colspan="1" rowspan="1">Males</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1">Phenotypes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Cognitive delay</td>
<td align="left" colspan="1" rowspan="1">+ (mild–moderate)</td>
<td align="left" colspan="1" rowspan="1">+ (moderate)</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+ (mild–moderate)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Failure to thrive</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Growth retardation</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Language delay</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Neuropsychiatric behaviors</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Microcephaly</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Craniofacial dysmorphia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Cleft/arched palate</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Digit abnormalities<xref ref-type="fn" rid="mgg3501-note-0006">[Link]</xref>
</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">MRI abnormalities</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Scoliosis</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Cardiac defects</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Hearing loss</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+ (unilateral)</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<title>Notes</title>
<fn id="mgg3501-note-0002">
<p>NA: no clinical information was provided.</p>
</fn>
<fn id="mgg3501-note-0003">
<p>Soardi et al. (<xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>).</p>
</fn>
<fn id="mgg3501-note-0004">
<p>Mullegama et al. (<xref ref-type="ref" rid="mgg3501-bib-0012">2017</xref>).</p>
</fn>
<fn id="mgg3501-note-0005">
<p>Bonnet et al. (<xref ref-type="ref" rid="mgg3501-bib-0003">2009</xref>), Di Benedetto et al. (<xref ref-type="ref" rid="mgg3501-bib-0005">2013</xref>), Leroy et al. (<xref ref-type="ref" rid="mgg3501-bib-0010">2016</xref>), Philippe et al. (<xref ref-type="ref" rid="mgg3501-bib-0014">2013</xref>) and Yingjun et al. (<xref ref-type="ref" rid="mgg3501-bib-0024">2015</xref>).</p>
</fn>
<fn id="mgg3501-note-0006">
<p>Polydactyly, syndactyly and 5th finger clinodactyly.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The utilization of exome sequencing has led to the discovery of novel X‐linked genetic disorders (Retterer et al., <xref ref-type="ref" rid="mgg3501-bib-0015">2016</xref>; Yang et al., <xref ref-type="ref" rid="mgg3501-bib-0023">2013</xref>). The clinical severity of females and males is most likely dependent on (a) the type of variant (missense vs. truncation); (b) location (within a functional domain); or (c) skewed X‐chromosome inactivation (XCi) (Chae, Hwang, Hwang, Cheong, &amp; Kim, <xref ref-type="ref" rid="mgg3501-bib-0004">2004</xref>; Weaving et al., <xref ref-type="ref" rid="mgg3501-bib-0022">2003</xref>). We had previously postulated that complete loss‐of‐function hemizygous variants that affect canonical STAG, SCD, or GR domains would not be identified in males because <italic>STAG2</italic> is an X‐linked gene and complete loss would result in embryonic lethality (Mullegama et al., <xref ref-type="ref" rid="mgg3501-bib-0012">2017</xref>). The pLys1009Asn variant found in our male proband is located on the protein surface (Figure <xref ref-type="fig" rid="mgg3501-fig-0001">1</xref>). It is possible that this variant affects protein stability, or interactions and ultimate assembly into the cohesion complex. We suspect that this mutation, based on surface location, may decrease the affinity of protein–protein or protein–DNA interactions, however, does not ablate them, which might explain the milder phenotype. In addition, the variant reported by Soardi et al. (<xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>) which was observed in male probands and shown to decrease the interaction between STAG2 and SCC1 which supports this hypothesis (Soardi et al., <xref ref-type="ref" rid="mgg3501-bib-0021">2017</xref>).</p>
<p>Upon comparing the limited <italic>STAG2</italic> patient cohort, we propose the following model. Females, who carry two copies of STAG2, are able to survive deleterious de novo variants, however display severe phenotypes. Males are unable to survive similar variants due to early embryologic lethality. Males are able to survive less damaging variants and as a result present with milder phenotypes. On the spectrum of male STAG2‐related cohesinopathies, we also see milder phenotypes in patients with chromosome Xq25 duplications suggesting that dosage and function are essential for proper cohesion complex function. Similar dosage effects have been established for <italic>MECP2</italic> (OMIM: 300005).</p>
<p>We believe that cohesinopathy/gene‐specific panels may be utilized by clinical geneticists when evaluating male patients with phenotypic constellations similar to the case herein reported. The major criteria are shared by all cohesinopathies and include cognitive delay, growth retardation, neuropsychiatric behavior abnormalities, microcephaly, dysmorphia, and digit anomalies. The true phenotypic spectrum will be expanded upon the discovery and reporting of additional male cases.</p>
<p>In conclusion, we report the first male de novo variant in <italic>STAG2</italic> and confirm that its function is essential for human growth and behavioral development. Overall, STAG2 is essential for human growth and behavioral development. The future identification of additional pathogenic variants in <italic>STAG2</italic> will allow us to further understand the phenotypic spectrum of this novel cohesinopathy.</p>
</sec>
<sec id="mgg3501-sec-0015" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>No conflict of interests.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="mgg3501-sup-0001">
<caption>
<p> </p>
</caption>
<media xlink:href="MGG3-7-na-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="mgg3501-sup-0002">
<caption>
<p> </p>
</caption>
<media xlink:href="MGG3-7-na-s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="mgg3501-sec-0014">
<title>ACKNOWLEDGMENTS</title>
<p>We are indebted to our patient and his family for participating in the study. This work was supported by UCLA Children's Discovery Institute, UCLA CART (NIH/NICHD Grant# P50‐HD‐055784, JAM‐A), NIH/NCATS UCLA CTSI (Grant # UL1TR000124, JAM‐A), Autism Speaks grant #9172 (SK), and the UCLA‐Caltech MSTP NIH T32GM008042 (SK).</p>
</ack>
<ref-list content-type="cited-references" id="mgg3501-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg3501-bib-0001">
<mixed-citation id="mgg3501-cit-0001" publication-type="journal">
<string-name>
<surname>Ball</surname>, <given-names>A. R.</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>Y. Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Yokomori</surname>, <given-names>K.</given-names>
</string-name> (<year>2014</year>). <article-title>Mechanisms of cohesin‐mediated gene regulation and lessons learned from cohesinopathies</article-title>. <source xml:lang="en"/>Biochimica Et Biophysica Acta, <volume>1839</volume>(<issue>3</issue>), <fpage>191</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2013.11.002</pub-id>
<pub-id pub-id-type="pmid">24269489</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0002">
<mixed-citation id="mgg3501-cit-0002" publication-type="journal">
<string-name>
<surname>Barbero</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2013</year>). <article-title>Genetic basis of cohesinopathies</article-title>. <source xml:lang="en"/>Application of Clinical Genetics, <volume>6</volume>, <fpage>15</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.2147/TACG.S34457</pub-id>
<pub-id pub-id-type="pmid">23882154</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0003">
<mixed-citation id="mgg3501-cit-0003" publication-type="journal">
<string-name>
<surname>Bonnet</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Leheup</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Beri</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Philippe</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Gregoire</surname>, <given-names>M. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Jonveaux</surname>, <given-names>P.</given-names>
</string-name> (<year>2009</year>). <article-title>Aberrant GRIA3 transcripts with multi‐exon duplications in a family with X‐linked mental retardation</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>149A</volume>(<issue>6</issue>), <fpage>1280</fpage>–<lpage>1289</lpage>.<pub-id pub-id-type="pmid">19449417</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0004">
<mixed-citation id="mgg3501-cit-0004" publication-type="journal">
<string-name>
<surname>Chae</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>, <given-names>Y. S.</given-names>
</string-name>, <string-name>
<surname>Cheong</surname>, <given-names>H. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Kim</surname>, <given-names>K. J.</given-names>
</string-name> (<year>2004</year>). <article-title>Influence of MECP2 gene mutation and X‐chromosome inactivation on the Rett syndrome phenotype</article-title>. <source xml:lang="en"/>Journal of Child Neurology, <volume>19</volume>(<issue>7</issue>), <fpage>503</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1177/08830738040190070501</pub-id>
<pub-id pub-id-type="pmid">15526954</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0005">
<mixed-citation id="mgg3501-cit-0005" publication-type="journal">
<string-name>
<surname>Di Benedetto</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Di Vita</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Romano</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Giudice</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Vitello</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Zingale</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Fichera</surname>, <given-names>M.</given-names>
</string-name> (<year>2013</year>). <article-title>6p22.3 deletion: Report of a patient with autism, severe intellectual disability and electroencephalographic anomalies</article-title>. <source xml:lang="en"/>Molecular Cytogenetics, <volume>6</volume>(<issue>1</issue>), <fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/1755-8166-6-4</pub-id>
<pub-id pub-id-type="pmid">23324214</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0006">
<mixed-citation id="mgg3501-cit-0006" publication-type="journal">
<string-name>
<surname>Gard</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Light</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Bose</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>McNairn</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Harris</surname>, <given-names>B.</given-names>
</string-name>, … <string-name>
<surname>Gerton</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2009</year>). <article-title>Cohesinopathy mutations disrupt the subnuclear organization of chromatin</article-title>. <source xml:lang="en"/>Journal of Cell Biology, <volume>187</volume>(<issue>4</issue>), <fpage>455</fpage>–<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200906075</pub-id>
<pub-id pub-id-type="pmid">19948494</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0007">
<mixed-citation id="mgg3501-cit-0007" publication-type="journal">
<string-name>
<surname>Gerkes</surname>, <given-names>E. H.</given-names>
</string-name>, <string-name>
<surname>van der Kevie‐Kersemaekers</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Yakin</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Smeets</surname>, <given-names>D. F.</given-names>
</string-name>, &amp; <string-name>
<surname>van Ravenswaaij‐Arts</surname>, <given-names>C. M.</given-names>
</string-name> (<year>2010</year>). <article-title>The importance of chromosome studies in Roberts syndrome/SC phocomelia and other cohesinopathies</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>53</volume>(<issue>1</issue>), <fpage>40</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2009.10.005</pub-id>
<pub-id pub-id-type="pmid">19878742</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0008">
<mixed-citation id="mgg3501-cit-0008" publication-type="journal">
<string-name>
<surname>Kumar</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Corbett</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Van Bon</surname>, <given-names>B. W.</given-names>
</string-name>, <string-name>
<surname>Gardner</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Woenig</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Jolly</surname>, <given-names>L. A.</given-names>
</string-name>, … <string-name>
<surname>Gecz</surname>, <given-names>J.</given-names>
</string-name> (<year>2015</year>). <article-title>Increased STAG2 dosage defines a novel cohesinopathy with intellectual disability and behavioral problems</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>24</volume>(<issue>25</issue>), <fpage>7171</fpage>–<lpage>7181</lpage>.<pub-id pub-id-type="pmid">26443594</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0009">
<mixed-citation id="mgg3501-cit-0009" publication-type="journal">
<string-name>
<surname>Lee</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Deignan</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Dorrani</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Strom</surname>, <given-names>S. P.</given-names>
</string-name>, <string-name>
<surname>Kantarci</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Quintero‐Rivera</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Nelson</surname>, <given-names>S. F.</given-names>
</string-name> (<year>2014</year>). <article-title>Clinical exome sequencing for genetic identification of rare Mendelian disorders</article-title>. <source xml:lang="en"/>JAMA, <volume>312</volume>(<issue>18</issue>), <fpage>1880</fpage>–<lpage>1887</lpage>.<pub-id pub-id-type="pmid">25326637</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0010">
<mixed-citation id="mgg3501-cit-0010" publication-type="journal">
<string-name>
<surname>Leroy</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Jacquemont</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Doray</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Lamblin</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Cormier‐Daire</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Philippe</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Malan</surname>, <given-names>V.</given-names>
</string-name> (<year>2016</year>). <article-title>Xq25 duplication: The crucial role of the STAG2 gene in this novel human cohesinopathy</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>89</volume>(<issue>1</issue>), <fpage>68</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">25677961</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0011">
<mixed-citation id="mgg3501-cit-0011" publication-type="journal">
<string-name>
<surname>McNairn</surname>, <given-names>A. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Gerton</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2008</year>). <article-title>Cohesinopathies: One ring, many obligations</article-title>. <source xml:lang="en"/>Mutation Research, <volume>647</volume>(<issue>1–2</issue>), <fpage>103</fpage>–<lpage>111</lpage>.<pub-id pub-id-type="pmid">18786550</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0012">
<mixed-citation id="mgg3501-cit-0012" publication-type="journal">
<string-name>
<surname>Mullegama</surname>, <given-names>S. V.</given-names>
</string-name>, <string-name>
<surname>Klein</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<surname>Mulatinho</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Senaratne</surname>, <given-names>T. N.</given-names>
</string-name>, <string-name>
<surname>Singh</surname>, <given-names>K.</given-names>
</string-name>, <collab collab-type="authors">UCLA Clinical Genomics Center</collab>
, … <string-name>
<surname>Martinez‐Agosto</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2017</year>). <article-title>De novo loss‐of‐function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>173</volume>(<issue>5</issue>), <fpage>1319</fpage>–<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38207</pub-id>
<pub-id pub-id-type="pmid">28296084</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0013">
<mixed-citation id="mgg3501-cit-0013" publication-type="journal">
<string-name>
<surname>Musio</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Krantz</surname>, <given-names>I. D.</given-names>
</string-name> (<year>2010</year>). <article-title>Cohesin biology and the cohesinopathies: Abstracts from the Second Biennial Conference, Pontignano, Italy, 2009</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>152A</volume>(<issue>7</issue>), <fpage>1630</fpage>–<lpage>1640</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33439</pub-id>
<pub-id pub-id-type="pmid">20583191</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0014">
<mixed-citation id="mgg3501-cit-0014" publication-type="journal">
<string-name>
<surname>Philippe</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Malan</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Jacquemont</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Boddaert</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Bonnefont</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<surname>Odent</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Cormier‐Daire</surname>, <given-names>V.</given-names>
</string-name> (<year>2013</year>). <article-title>Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X‐linked intellectual disability with distinctive facial appearance</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>161A</volume>(<issue>6</issue>), <fpage>1370</fpage>–<lpage>1375</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35307</pub-id>
<pub-id pub-id-type="pmid">23637084</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0015">
<mixed-citation id="mgg3501-cit-0015" publication-type="journal">
<string-name>
<surname>Retterer</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Juusola</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Cho</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<surname>Vitazka</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Millan</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Gibellini</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Bale</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Clinical application of whole‐exome sequencing across clinical indications</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>18</volume>(<issue>7</issue>), <fpage>696</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.148</pub-id>
<pub-id pub-id-type="pmid">26633542</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0016">
<mixed-citation id="mgg3501-cit-0016" publication-type="journal">
<string-name>
<surname>Richards</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Bale</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bick</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gastier‐Foster</surname>, <given-names>J.</given-names>
</string-name>, … <collab collab-type="authors">ACMG Laboratory Quality Assurance Committee</collab>
(<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>17</volume>(<issue>5</issue>), <fpage>405</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0017">
<mixed-citation id="mgg3501-cit-0017" publication-type="miscellaneous">
<string-name>
<surname>Schrodinger</surname>, <given-names>L. L. C.</given-names>
</string-name> (<year>2015a</year>). <article-title>The AxPyMOL molecular graphics plugin for microsoft powerpoint. Version, 1.8</article-title>.</mixed-citation>
</ref>
<ref id="mgg3501-bib-0018">
<mixed-citation id="mgg3501-cit-0018" publication-type="miscellaneous">
<string-name>
<surname>Schrodinger</surname>, <given-names>L. L. C.</given-names>
</string-name> (<year>2015b</year>). <article-title>The JyMOL molecular graphics development component. Version, 1.8</article-title>.</mixed-citation>
</ref>
<ref id="mgg3501-bib-0019">
<mixed-citation id="mgg3501-cit-0019" publication-type="miscellaneous">
<string-name>
<surname>Schrodinger</surname>, <given-names>L. L. C.</given-names>
</string-name> (<year>2015c</year>). <article-title>The PyMOL molecular graphics system. Version, 1.8</article-title>.</mixed-citation>
</ref>
<ref id="mgg3501-bib-0020">
<mixed-citation id="mgg3501-cit-0020" publication-type="journal">
<string-name>
<surname>Skibbens</surname>, <given-names>R. V.</given-names>
</string-name>, <string-name>
<surname>Colquhoun</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Green</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Molnar</surname>, <given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Sin</surname>, <given-names>D. N.</given-names>
</string-name>, <string-name>
<surname>Sullivan</surname>, <given-names>B. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Tanzosh</surname>, <given-names>E. E.</given-names>
</string-name> (<year>2013</year>). <article-title>Cohesinopathies of a feather flock together</article-title>. <source xml:lang="en"/>PLoS Genetics, <volume>9</volume>(<issue>12</issue>), <fpage>e1004036</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004036</pub-id>
<pub-id pub-id-type="pmid">24367282</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0021">
<mixed-citation id="mgg3501-cit-0021" publication-type="journal">
<string-name>
<surname>Soardi</surname>, <given-names>F. C.</given-names>
</string-name>, <string-name>
<surname>Machado‐Silva</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Linhares</surname>, <given-names>N. D.</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Qu</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Pena</surname>, <given-names>H. B.</given-names>
</string-name>, … <string-name>
<surname>Pena</surname>, <given-names>S. D. J.</given-names>
</string-name> (<year>2017</year>). <article-title>Familial STAG2 germline mutation defines a new human cohesinopathy</article-title>. <source xml:lang="en"/>NPJ Genomic Medicine, <volume>2</volume>(<issue>1</issue>), <fpage>7</fpage>
<pub-id pub-id-type="doi">10.1038/s41525-017-0009-4</pub-id>
<pub-id pub-id-type="pmid">29263825</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0022">
<mixed-citation id="mgg3501-cit-0022" publication-type="journal">
<string-name>
<surname>Weaving</surname>, <given-names>L. S.</given-names>
</string-name>, <string-name>
<surname>Williamson</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Bennetts</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Davis</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ellaway</surname>, <given-names>C. J.</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Christodoulou</surname>, <given-names>J.</given-names>
</string-name> (<year>2003</year>). <article-title>Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>118A</volume>(<issue>2</issue>), <fpage>103</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.10053</pub-id>
<pub-id pub-id-type="pmid">12655490</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0023">
<mixed-citation id="mgg3501-cit-0023" publication-type="journal">
<string-name>
<surname>Yang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Muzny</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Reid</surname>, <given-names>J. G.</given-names>
</string-name>, <string-name>
<surname>Bainbridge</surname>, <given-names>M. N.</given-names>
</string-name>, <string-name>
<surname>Willis</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ward</surname>, <given-names>P. A.</given-names>
</string-name>, … <string-name>
<surname>Eng</surname>, <given-names>C. M.</given-names>
</string-name> (<year>2013</year>). <article-title>Clinical whole‐exome sequencing for the diagnosis of mendelian disorders</article-title>. <source xml:lang="en"/>New England Journal of Medicine, <volume>369</volume>(<issue>16</issue>), <fpage>1502</fpage>–<lpage>1511</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1306555</pub-id>
<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="mgg3501-bib-0024">
<mixed-citation id="mgg3501-cit-0024" publication-type="journal">
<string-name>
<surname>Yingjun</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Wen</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Yujian</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Lingling</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Huimin</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Qun</surname>, <given-names>F.</given-names>
</string-name>, &amp; <string-name>
<surname>Junhong</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>Microduplication of chromosome Xq25 encompassing STAG2 gene in a boy with intellectual disability</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>58</volume>(<issue>2</issue>), <fpage>116</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2014.10.002</pub-id>
<pub-id pub-id-type="pmid">25450604</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>